We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
-2.29%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$592M
AUM Growth
-$30.3M
Cap. Flow
-$9.05M
Cap. Flow %
-1.53%
Top 10 Hldgs %
59.76%
Holding
37
New
3
Increased
13
Reduced
9
Closed
3

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$16.9M
2
UTHR icon
United Therapeutics
UTHR
+$11.9M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$10.1M
4
ELAN icon
Elanco Animal Health
ELAN
+$6.96M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$5.39M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$14.6M
2
ABT icon
Abbott
ABT
+$12.7M
3
BIO icon
Bio-Rad Laboratories Class A
BIO
+$12.6M
4
VTRS icon
Viatris
VTRS
+$9.61M
5
CVS icon
CVS Health
CVS
+$9.58M

Sector Composition

Rank Sector Weight
1 Healthcare 99.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMY icon
1
Bristol-Myers Squibb
BMY
$124B
$70.3M 11.88%
1,386,722
+35,000
+3% +$1.64M
BSX icon
2
Boston Scientific
BSX
$65.4B
$45.1M 7.62%
1,108,336
– –
ABT icon
3
Abbott
ABT
$175B
$45M 7.6%
537,260
-150,000
-22% -$12.7M
BAX icon
4
Baxter International
BAX
$11.7B
$41.3M 6.98%
472,305
+10,000
+2% +$854K
GILD icon
5
Gilead Sciences
GILD
$167B
$30.1M 5.09%
475,056
+30,000
+7% +$1.96M
NUVA
6
DELISTED
NuVasive, Inc.
NUVA
$29.7M 5.01%
468,258
-31,096
-6% -$1.94M
INCY icon
7
Incyte
INCY
$23.4B
$25.7M 4.34%
345,893
+32,000
+10% +$2.59M
RVTY icon
8
Revvity
RVTY
$12.3B
$25.6M 4.32%
300,198
– –
REGN icon
9
Regeneron Pharmaceuticals
REGN
$70.9B
$21M 3.55%
75,835
+18,200
+32% +$5.39M
A icon
10
Agilent Technologies
A
$37.1B
$19.9M 3.37%
260,293
-28,772
-10% -$2.08M
ELV icon
11
Elevance Health
ELV
$80.9B
$17.9M 3.03%
74,607
+1,500
+2% +$411K
LLY icon
12
Eli Lilly
LLY
$1.05T
$17M 2.87%
+152,105
New +$16.9M
QGEN icon
13
Qiagen
QGEN
$8.49B
$16M 2.7%
457,006
+57,621
+14% +$2.22M
BIO icon
14
Bio-Rad Laboratories Class A
BIO
$8.15B
$15.4M 2.61%
46,368
-38,658
-45% -$12.6M
PRGO icon
15
Perrigo
PRGO
$1.48B
$14.4M 2.43%
257,844
-20,000
-7% -$1.02M
TAK icon
16
Takeda Pharmaceutical
TAK
$54.8B
$14M 2.37%
816,299
+20,000
+3% +$346K
BRKR icon
17
Bruker
BRKR
$8.86B
$13.5M 2.29%
308,004
+85,000
+38% +$3.81M
BIIB icon
18
Biogen
BIIB
$30.4B
$12.2M 2.06%
52,426
-62,700
-54% -$14.6M
UTHR icon
19
United Therapeutics
UTHR
$22.7B
$11.8M 2%
+148,147
New +$11.9M
HUM icon
20
Humana
HUM
$48B
$11.2M 1.9%
43,999
-22,901
-34% -$6.42M
ELAN icon
21
Elanco Animal Health
ELAN
$12.9B
$11.1M 1.87%
417,042
+232,000
+125% +$6.96M
UHS icon
22
Universal Health Services
UHS
$9.15B
$9.63M 1.63%
64,742
– –
THC icon
23
Tenet Healthcare
THC
$16.8B
$9.5M 1.61%
429,677
+101,015
+31% +$2.15M
CAH icon
24
Cardinal Health
CAH
$53.5B
$9.31M 1.57%
197,299
– –
ALXN
25
DELISTED
Alexion Pharmaceuticals
ALXN
$8.81M 1.49%
+89,964
New +$10.1M
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q3 2019 Portfolio in Review

As of Q3 2019, Sector Gamma AS held 37 positions worth $592M, down 4.9% from $622M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Sector Gamma AS's Q3 2019 filing shows 3 new, 13 increased, 9 reduced and 3 closed positions. Its largest new stake was Eli Lilly: 152,105 shares worth $17M. The largest sale was Biogen, an estimated $14.6M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 99% a quarter earlier.

  • Sector Gamma AS's largest Q3 2019 buy was Eli Lilly: 152,105 shares worth $17M.
  • Sector Gamma AS added most to Elanco Animal Health in Q3 2019, an estimated $6.96M increase.
  • Sector Gamma AS's biggest Q3 2019 reduction was Biogen, cutting an estimated $14.6M.
  • Sector Gamma AS fully exited Viatris in Q3 2019, selling an estimated $9.61M.
  • Sector Gamma AS's ten largest holdings make up 60% of its $592M portfolio in Q3 2019.
  • Sector Gamma AS opened 3 new positions and closed 3 in Q3 2019.
  • Sector Gamma AS's portfolio value fell 4.9% quarter-over-quarter to $592M.

Based on Sector Gamma AS's 13F filing for Q3 2019, filed 5 Nov 2019.